Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
ProBioGen AG is a renowned international Contract Development and Manufacturing Organization (CDMO) based in Berlin, Germany. With over 25 years of experience, ProBioGen specializes in the development and manufacturing of complex biopharmaceutical active ingredients, including therapeutic proteins and viral vectors for vaccines and gene therapy. They offer a wide range of services, from cell line engineering (including their proprietary CHO.RiGHT® expression platform and GlymaxX® technology), process development, and GMP manufacturing to innovative analytical development. ProBioGen is known for its scientific excellence, cutting-edge technologies, and commitment to quality, serving biotech and pharmaceutical companies worldwide.
The Berlin headquarters serves as the central hub for all company operations, including research and development, process development, GMP manufacturing, quality control, business development, and corporate administration.
The facility houses state-of-the-art laboratories, GMP-compliant cleanroom suites for manufacturing, advanced analytical equipment, and modern office spaces designed to foster collaboration and innovation.
ProBioGen fosters a science-driven, innovative, and collaborative work environment. Employees often highlight the company's commitment to quality, cutting-edge projects, and opportunities for professional growth in the dynamic biopharmaceutical sector.
The Berlin headquarters is strategically significant due to its central European location, proximity to a strong biotech ecosystem, and its role as the core site for ProBioGen's technological advancements and service delivery.
ProBioGen AG operates globally, providing its specialized CDMO services to a diverse international clientele. While its primary development and manufacturing facilities are in Berlin, Germany, the company supports projects for pharmaceutical and biotechnology companies across Europe, North America, Asia, and other regions. Its US office in Cambridge, MA, strengthens its presence in the key North American market. ProBioGen's technologies and services are utilized by partners worldwide for developing and manufacturing biopharmaceuticals for global health needs.
Herbert-Bayer-Str. 8
Berlin
Berlin
Germany
Address: One Broadway, 14th Floor, Cambridge, MA 02142, USA (ProBioGen US, Inc.)
To enhance ProBioGen's accessibility and service to its growing customer base in North America, facilitating easier communication and collaboration across time zones.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ProBioGen AG' leadership includes:
ProBioGen AG has been backed by several prominent investors over the years, including:
ProBioGen AG saw a key transition in its scientific leadership, with Dr. Volker Sandig appointed as CSO following the retirement of Dr. Gabriele Schneider.
Discover the tools ProBioGen AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ProBioGen AG primarily uses the 'first.last' email format. Understanding this common structure can be helpful for professional communication.
first.last@probiogen.de
Format
jane.doe@probiogen.de
Example
90%
Success rate
ProBioGen Website • May 7, 2024
ProBioGen announced a collaboration with Merck to develop an end-to-end manufacturing platform for viral vectors, aiming to streamline processes and improve efficiency in gene therapy production....more
ProBioGen Website • November 29, 2023
ProBioGen and Prime Vector Technologies (PVT) have initiated a collaboration to advance the development of adenoviral vector-based vaccines, leveraging ProBioGen's expertise in vector development and manufacturing....more
ProBioGen Website • October 11, 2023
ProBioGen announced the successful completion of a cell line development project for Sanofi, supporting their program for a novel therapeutic candidate targeting multiple myeloma. This utilized ProBioGen's CHO.RiGHT® expression platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ProBioGen AG, are just a search away.